Novel Diterpenoid Acetylcholinesterase Inhibitors from Salvia miltiorhiza

 

 Permissions and Reprints

Abstract

Acetylcholinesterase (AChE, EC 3.1.1.7) inhibitors are the only registered drugs used to treat Alzheimer’s disease (AD). New AChE inhibitors may contribute to the design of new pharmaceuticals and supply information which will facilitate the understanding of the interaction between inhibitors and the enzyme. The dried root of Salvia miltiorhiza is called ‘Danshen’ in China, and has been used for the treatment of cerebrovascular disease and CNS deterioration in old age for over one thousand years. In this work, a modified Ellman method was used to guide the fractionation of the active AChE inhibitory compounds from an acetone extract. Four inhibitory compounds, dihydrotanshinone, cryptotanshinone, tanshinone I and tanshinone IIA were isolated, and the structures were identified by comparison of their spectral characteristics with previous reports. The inhibitory activities of dihydrotanshinone and cryptotanshinone were dose-dependent, their IC₅₀ values being 1.0 μM and 7.0 μM, respectively. These two compounds were the major inhibitory compounds in the extract as judged by HPLC analysis, forming 0.054 % w/w and 0.23 % w/w in the dried root, respectively, and in mixture they appear to be less active than as isolated compounds. The clogP values of dihydrotanshinone, cryptotanshinone, tanshinone I and tanshinone IIA were calculated as 2.4, 3.4, 4.8 and 5.8, respectively, which indicate that these compounds have potential to penetrate the blood-brain barrier. This is the first example of diterpenoids as inhibitors of AChE.

References

• 1 Massoulié J, Pezzementi L, Bon S. Molecular and cellular biology of cholinesterases.  Prog Neurobiol. 1993;  41 31-91
  CrossrefPubMedGoogle Scholar
• 2 Bartus R T, Dean RL 3 rd, Beer B, Lippa A S. The cholinergic hypothesis of geriatric memory dysfunction.  Science. 1982;  217 408-14
  CrossrefPubMedGoogle Scholar
• 3 Giacobini E. Pharmacotherapy of Alzheimer’s disease: New drugs and novel strategies.  Prog Brain Res. 1993;  98 447-54
  PubMedGoogle Scholar
• 4 Kuang P, Xiang J. Effect of Radix Salviae miltiorhizae on EAA and IAA during cerebral ischemia in gerbils: a microdialysis study.  J Trad Chin Med. 1994;  14 45-50
  PubMedGoogle Scholar
• 5 Massiah M A, Viragh C, Reddy P M, Kovach I M, Johnson J, Rosenberry T L. Short, strong hydrogen bonds at the active site of human acetylcholinesterase: proton NMR studies.  Biochemistry. 2001;  40 5682-90
  CrossrefPubMedGoogle Scholar
• 6 Onitsuka M, Fujiu M, Shinma N, Maruyama H B. Novel diterpenoids from Salvia miltiorhiza .  Chem Pharm Bull. 1983;  31 1670-5
  PubMedGoogle Scholar
• 7 Ikeshiro Y, Hashimoto I, Iwamoto Y. Diterpenoids from Salvia miltiorhiza .  Phytochemistry. 1991;  30 2791-2
  CrossrefPubMedGoogle Scholar
• 8 Ryu S Y, Oak M -H, Kim K -M. Inhibition of Mast cell degranulation by tanshinones from the roots of Salvia miltiorhiza .  Planta Med. 1999;  65 654-5
  PubMedGoogle Scholar
• 9 Perry N SL, Houghton P J, Theobald A E, Jenner P, Perry E K. In-vitro inhibition of human erythrocyte acetylcholine esterase by Salvia lavandulaefolia essential oil and constituent terpenes.  J Pharm Pharmacol. 2002;  52 895-902
  PubMedGoogle Scholar
• 10 Orhan I, Terzioglu S, Sener B. alpha-Onocerin: an acetylcholinesterase inhibitor from Lycopodium clavatum .  Planta Med. 2003;  69 265-7
  Article in Thieme ConnectPubMedGoogle Scholar
• 11 Miyazawa M, Watanabe H, Umemoto K. Inhibition of acetylcholinesterase activity by monoterpenoids with a p-menthane skeleton.  J Agric Food Chem. 1997;  45 667-9
  PubMedGoogle Scholar
• 12 Chang H M, Cheng K P, Chong T F. Structure elucidation and total synthesis of new tanshinones isolated from Salvia miltiorhiza Bung.  J Org Chem. 1990;  55 3537-43
  CrossrefPubMedGoogle Scholar
• 13 Pan X, Niu G, Liu H. Microwave-assisted extraction of tanshinones from Salvia miltiorhiza Bunge with analysis by HPLC.  J Chrom A. 2001;  922 371-5
  CrossrefPubMedGoogle Scholar
• 14 Kang B Y, Chung S W, Kim S H, Ryu S Y, Kim T S. Inhibition of interleukin-12 and interferon-gamma production in immune cells by tanshinones from Salvia miltiorhiza .  Immunopharmacology. 2000;  49 355-61
  CrossrefPubMedGoogle Scholar
• 15 Tezuka Y, Kasimu R, Basnet P. Aldose reductase inhibitory constituents of the root of Salvia miltiorhiza Bunge.  Chem Pharm Bull (Tokyo). 1997;  45 1306-11
  PubMedGoogle Scholar
• 16 Korpela M, Tahti H. The effect of selected organic solvents on intact human red cell membrane acetylcholinesterase in vitro .  Toxicol Appl Pharmacol. 1986;  85 257-62
  CrossrefPubMedGoogle Scholar
• 17 Maatooq G T, Hoffmann J J. Microbial transformation of a mixture of argentatin A and incanilin.  Z Naturforsch [C]. 2002;  57 489-95
  PubMedGoogle Scholar

Prof. Peter Houghton

Department of Pharmacy

King’s College London

Franklin-Wilkins Building

150 Stamford Street

London SE1 9NN

U.K.

Fax: +44-20-7848-4800

Email: peter.houghton@kcl.ac.uk